Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.79) by 5.06 percent. This is a 74.38 percent increase over losses of $(3.24) per share from the same period last year. The company reported quarterly sales of $27.863 million which missed the analyst consensus estimate of $28.900 million by 3.59 percent. This is a 6.35 percent decrease over sales of $29.752 million the same period last year.